The perimenopausal transition

Annals of the New York Academy of Sciences

Volumn 900, Issue , 2000, Pages 375-392

  Speroff, Leon ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; ESTROGEN; FOLLITROPIN; INHIBIN; LUTEINIZING HORMONE;

ADRENERGIC SYSTEM; ALCOHOL ABUSE; BREAST CANCER; CARDIOVASCULAR DISEASE; CONFERENCE PAPER; DIABETES MELLITUS; FAMILY PLANNING; FAMILY VIOLENCE; FEMALE; HUMAN; HYPERTENSION; HYPOTHYROIDISM; IMMUNIZATION; MENOPAUSE; MENSTRUAL CYCLE; MENSTRUAL IRREGULARITY; NEUROPHYSIOLOGY; NUTRITION; OSTEOPOROSIS; PHYSICAL ACTIVITY; SEXUALITY; SMOKING;

EID: 0034019392     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2000.tb06250.x     Document Type: Conference Paper

References (75)

1. 1. VOLLMAN, R.F. 1977. The menstrual cycle. In Major Problems in Obstetrics and Gynecology. E. Friedman, Ed. W.B. Saunders Co. Philadelphia.
2. 2. TRELOAR, A.E., R.E. BOYNTON, G.B. BORGHILD & B.W. BROWN. 1967. Variation of the human menstrual cycle through reproductive life. Int. J. Fertil. 12: 77-126.
3. 3. COLLETT, M.E., G.E. WERTENBERGER & V.M. FISKE. 1954. The effect of age upon the pattern of the menstrual cycle. Fertil. Steril. 5: 437.
4. 4. MUNSTER, K., L. SCHMIDT & P. HELM. 1992. Length and variation in the menstrual cycle - a cross-sectional study from a Danish county. Br. J. Obstet. Gynaecol. 99: 422.
5. 5. BELSEY, E.M., A.P.Y. PINOL & TASK FORCE ON LONG-ACTING SYSTEMIC AGENTS FOR FERTILITY REGULATION. 1997. Menstrual bleeding patterns in untreated women. Contraception 55: 57-65.
6. 6. SHERMAN, B.M., J.H. WEST & S.G. KORENMAN. 1976. The menopausal transition: analysis of lh, fsh, estradiol, and progesterone concentrations during menstrual cycles of older women. J. Clin. Endocrinol. Metab. 42: 629.
7. 7. LENTON, E.A., B. LANDGREN, L. SEXTON & R. HARPER. 1984. Normal variation in the length of the follicular phase of the menstrual cycle: effect of chronological age. Br. J. Obstet. Gynaecol. 91: 681.
8. 8. BUCKLER, H.M., A. EVANS, H. MAMLORA et al. 1991. Gonadotropin, steroid and inhibin levels in women with incipient ovarian failure during anovulatory and ovulatory 'rebound' cycles. J. Clin. Endocrinol. Metab. 72: 116-124.
9. 9. MACNAUGHTON, J., M. BANGAH, P. MCCLOUD et al. 1992. Age-related changes in follicle stimulating hormone, luteinizing hormone, oestradiol and immunoreactive inhibin in women of reproductive age. Clin. Endocrinol. 36: 339.
10. 10. HEE, J., J. MACNAUGHTON, M. BANGAH & H.G. BURGER. 1993. Perimenopausal patterns of gonadotrophins, immunoreactive inhibin, oestradiol and progesterone. Maturitas 18: 9-20.
11. 11. METCALF, M.G. & J.H. LIVESAY. 1985. Gonadotropin excretion in fertile women: effect of age and the onset of the menopausal transition. J. Endocrinol. 105: 357.
12. 12. RANNEVIK, G., S. JEPPSSON, O. JOHNELL et al. 1995. A longitudinal study of the perimenopausal transition: altered profiles of steroid and pituitary hormones, SHBG and bone mineral density. Maturitas 21: 103-113.
13. 13. SANTORO, N., J.R. BROWN, T. ADEL & J.H. SKURNICK. 1996. Characterization of reproductive hormonal dynamics in the perimenopause. J. Clin. Endocrinol. Metab. 81: 1495-1501.
14. 14. RICHARDSON, S.J., V. SENIKAS & J.F. NELSON. 1987. Follicular depletion during the menopausal transition - evidence for accelerated loss and ultimate exhaustion. J. Clin. Endocrinol. Metab. 65: 1231-1237.
15. 15. GOUGEON, A., R. ECHOCHARD & J.C. THALABARD. 1994. Age-related changes of the population of human ovarian follicles: increase in the disappearance rate of nongrowing and early-growing follicles in aging women. Biol. Reprod. 50: 653-663.
16. 16. FADDY, M.J., R.G. GOSDEN, A. GOUGEON et al. 1992. Accelerated disappearance of ovarian follicles in mid-life: implications for forecasting menopause. Hum. Reprod. 7: 1342-1346.
17. 17. KLEIN, N.A., P.J. ILLINGWORTH, N.P. GROOME et al. 1996. Decreased inhibin B secretion is associated with the monotropic FSH rise in older, ovulatory women: a study of serum and follicular fluid leavels of dimeric inhihin A and B in spontaneous menstrual cycles. J. Clin. Endocrinol. Metab. 81: 2742-2745.
18. 18. MCKINLAY, S.M., D.J. BRAMBILLA & J.G. POSNER. 1992. The normal menopause transition. Maturitas 14: 103-115.
19. 19. TRELOAR, A.E. 1981. Menstrual cyclicity and the pre-menopause. Maturitas 3: 249-264.
20. 20. DAVIS, D.L., G.E. DINSE & D.G. HOEL. 1994. Decreasing cardiovascular disease and increasing cancer among whites in the United States from 1973 through 1987. JAMA 271: 431.
21. 21. KRONNENBERG, F. & R.M. BARNARD. 1992. Modulation of menopausal hot flashes by ambient temerature. J. Therm. Biol. 17: 43-49.
22. 22. HUNTER, M. 1992. The South-East England longitudinal study of the climacteric and postmenopause. Maturitas 14: 17-26.
23. 23. OLDENHAVE, A., L.J.B. JASZMANN, A.A. HASPELS & W.T.A.M. EVERAERD. 1993. Impact of climacteric on well-being. Am. J. Obstet. Gynecol. 168: 772-780.
24. 24. GUTHRIE, J.R., L. DENNERSTEIN, J.L. HOPPER & H.G. BURGER. 1996. Hot flushes, menstrual status, and hormone levels in a population-based sample of midlife women. Obstet. Gynecol. 88: 437-442.
25. 25. SCHWINGL, P.J., B.S. HULKA & S.D. HARLOW. 1994. Risk factors for menopausal hot flashes. Obstet. Gynecol. 84: 29-34.
26. 26. PHAM, K.T., J.A. GRISSO & E.W. FREEMAN. 1997. Ovarian aging and hormone replacement therapy. Hormonal levels, symptoms, and attitudes of African-American and white women. J. Gen. Intern. Med. 12: 230-236.
27. 27. KRONNENBERG, F. 1990. Hot flashes: epidemiology and physiology. Ann. N.Y. Acad. Sci. 592: 52-86.
28. 28. WILKIN, J.R. 1981. Flushing reactions: consequences and mechanisms. Ann. Intern. Med. 95: 468-476.
29. 29. MOHYI, D., K. TABASSI & J. SIMON. 1997. Differential diagnosis of hot flashes. Maturitas 27: 203-214.
30. 30. PEARCE, J., K. HAWTON, F. BLAKE et al. 1997. Psychological effects of continuation versus discontinuation of hormone replacement therapy by estrogen implants: a placebo-controlled study. J. Psychosom. Res. 42: 177-186.
31. 31. BALLINGER, C.B. 1990. Psychiatric aspects of the menopause. Br. J. Psychiatr. 156: 773-787.
32. 32. SCHMIDT, P.J. & D.R. RUBINOW. 1991. Menopause-related affective disorders: a justification for further study. Am. J. Psychiatr. 148: 844-854.
33. 33. HÄLLSTRÖM, T. & S. SAMUELSSON. 1985. Mental health in the climacteric. The longitudinal study of women in Gothenburg. Acta Obstet. Gynecol. Scand. (Suppl.) 130: 13-18.
34. 34. GATH, D., M. OSBORN & G. BUNGAY et al. 1987. Psychiatric disorder and gynaecological symptoms in middle aged women: a community survey. Br. Med. J. 294: 213-218.
35. 35. MCKINLAY, S.M. & J.B. MCKINLAY. 1989. The impact of menopause and social factors on health. In Menopause: Evaluation, Treatment, and Health Concerns. C.B. Hammond, F.P. Haseltine & I. Schiff, Eds. :137-161. Alan R. Liss. New York.
36. 36. MATTHEWS, K.A., R.R. WING, L.H. KULLER et al. 1990. Influences of natural menopause on psychological characteristics and symptoms of middle-aged healthy women. J. Consult. Clin. Psychol. 58: 345-351.
37. 37. KOSTER, A. 1991. Change-of-life anticipations, attitudes, and experiences among middle-aged Danish women. Health Care Women Int. 12: 1-13.
38. 38. HOLTE, A. 1992. Influences of natural menopause on health complaints: a prospective study of healthy Norwegian women. Maturitas 14: 127.
39. 39. KAUFERT, P.A., P. GILBERT & R. TATE. 1992. The Manitoba Project: a re-examination of the link between menopause and depression. Maturitas 14: 143.
40. 40. DENNERSTEIN, L., A.M.A. SMITH, C. MORSE et al. 1993. Menopausal symptoms in Australian women. Med. J. Aust. 159: 232.
41. 41. EVERSON, S.A., K.A. MATTHEWS, D.S. GUZICK et al. 1995. Effects of surgical menopause on lipid levels and psychosocial characteristics: the Healthy Women Study. Health Psychol. 14: 435-443.
42. 42. AVIS, N.E., D. BRAMBILLA, S.M. MCKINLAY & K. VASS. 1994. A longitudinal analysis of the association between menopause and depression. Results from the Massachusetts Women's Health Study. Ann. Epidemiol. 4: 214-220.
43. 43. KESSLER, R.C., K.A. MCGONAGLE, M. SWARTZ et al. 1993. Sex and depression in the National Comorbidity Survey I: lifetime prevalence, chronicity and recurrence. J. Affect. Disord. 29: 85.
44. 44. BUSCH, C.M., A.B. ZONDERMAN & P.T. COSTA, JR. 1994. Menopausal transition and psychological distress in a nationally representative sample: is menopause associated with psychological distress? J. Aging Health 6: 209-228.
45. 45. DENNERSTEIN, L., A.M.A. SMITH & C. MORSE. 1994. Psychological well-being, mid-life and the menopause. Maturitas 20: 1.
46. 46. MITCHELL, E.S. & N.F. WOODS. 1996. Symptom experiences of midlife women: observations from the Seattle midlife women's health study. Maturitas 25: 1-10.
47. 47. VAN HALL, E.V., M, VERDEL & J. VAN DER VELDEN. 1994. "Perimenopausal" complaints in women and men: a comparative study. J. Women's Health 3: 45-49.
48. 48. CAMPBELL, S. & M. WHITEHEAD. 1977. Estrogen therapy and the menopausal syndrome. Clin. Obstet. Gynecol. 4: 31-47.
49. 49. MORSE, C.A., A. SMITH, L. DENNERSTEIN et al. 1994. The treatment-seeking woman at menopause. Maturitas 18: 161-173.
50. 50. WIKLUND, I., J. KARLBERG & L.-A. MATTSSON. 1993. Quality of life of postmenopausal women on a regimen of transdermal estradiol therapy: a double-blind placebo-controlled study. Am. J. Obstet. Gynecol. 168: 824-830.
51. 51. DALY, E., A. GRAY, D. BARLOW et al. 1993. Measuring the impact of menopausal symptoms on quality of life. Br. Med. J. 307: 836.
52. 52. WOODWARD, S. & R.R. FREEDMAN. 1994. The thermoregulatory effects of menopausal hot flashes on sleep. Sleep 17: 497-501.
53. 53. SCHIFF, I., Q. REGESTEIN, D. TULCHINSKY & K.J. RYAN. 1979. Effects of estrogens on sleep and psychological state of hypogonadal women. JAMA 242: 2405-2407.
54. 54. DENNERSTEIN, L., G.D. BURROWS, G.J. HYMAN & C. WOOD. 1979. Hormone therapy and affect. Maturitas 1: 247-254.
55. 55. SHERWIN, B.B. 1988. Affective changes with estrogen and androgen replacement therapy in surgically menopausal women. J. Affect. Disord. 14: 177-187.
56. 56. PALINKAS, L.A. & E. BARRETT-CONNOR. 1992. Estrogen use and depressive symptoms in postmenopausal women. Obstet. Gynecol. 80: 30-36.
57. 57. LIMOUZIN-LAMOTHE, M.-A., N. MAIRON, C.R.B. JOYCE & M. LE GAL. 1994. Quality of life after the menopause: influence of hormonal replacement therapy. Am. J. Obstet. Gynecol. 170: 618-624.
58. 58. SCHNEIDER, L.S., G.W. SMALL, S.H. HAMILTON et al. 1997. Estrogen replacement and response to fluoxetine in a multicenter geriatric depression trial. Am. J. Geriatr Psychiatry 5: 97-106.
59. 59. BARAN, D., A. SORENSEN, J. GRIMES et al. 1990. Dietary modification with dairy products for preventing vertebral bone loss in premenopausal women: a three-year prospective study. J. Clin. Endocrinol. Metab. 70: 264-270.
60. 60. ELDERS, P.J.M., P. LIPS, C. NETELENBOS et al. 1994. Long-term effect of calcium supplementation on bone loss in perimenopausal women. J. Bone Miner. Res. 9: 963.
61. 61. GAMBACCIANI, M., A. SPINETTI, F. TAPONECO et al. 1994. Bone loss in perimenopausal women: a longitudinal study. Maturitas 18: 191-197.
62. 62. GARTON, M., J. MARTIN, S. NEW et al. 1996. Bone mass and metabolism in women aged 45-55. Clin. Endocrinol. 44: 536-570.
63. 63. WALLER, K., J. REIM, L. FENSTER et al. 1996. Bone mass and subtle abnormalities in ovulatory function in healthy women. J. Clin. Endocrinol. Metab. 81: 663-668.
64. 64. DE SOUZA, M.J., B.E. MILLER, L.C. SEQUENZIA et al. 1997. Bone health is not affected by luteal phase abnormalities and decreased ovarian progesterone production in female runners. J. Clin. Endocrinol. Metab. 82: 2867-2876.
65. 65. AMERICAN CANCER SOCIETY. 1998. Cancer facts & figures - 1998. http://www.cancer.org/statistics.
66. 66. EDDY, D.M, V. HASSELBLAD, W. MCGIVNEY & W. HENDEE. 1988. The value of mammography screening in women under age 50 years. JAMA 259: 1512.
67. 67. MILLER, A.B., C.J. BAINES, T. TO & C. WALL. 1992. Canadian National Breast Screening Study: 1. Breast cancer detection and death rates among women aged 40 to 49 years. Can. Med. Assoc. J. 147: 1459.
68. 68. STACEY-CLEAR, A., K.A. MCCARTHY, D.A. HALL et al. 1992. Breast cancer survival among women under age 50: is mammography detrimental? Lancet 340: 991.
69. 69. BJURSTAM, N., L. BJÖRNELD, S.W. DUFFY et al. 1997. The Gothenhurg Breast Screening Trial. First results on mortality, incidence, and mode of detection for women ages 39-49 years at randomization. Cancer 80: 2091-2099.
70. 70. SMART, C.R., R.E. HENDRICK, J.H. RUTLEDGE, III, & R.A. SMITH. 1995. Benefit of mammography screening in women ages 40-49 years: current evidence from randomized controlled trials. Cancer 75: 1619.
71. 71. CURPEN, B.N., E.A. SICKLES, R.A. SOLLITO et al. 1995. The comparative value of mammographic screening for women 40-49 years old versus women 50-64 years old. Am. J. Roentgenol. 164: 1099.
72. 72. KERLIKOWSKE, K., D. GRADY, J. BARCLAY et al. 1996. Effect of age, breast density, and family history on the sensitivity of first screening mammography. JAMA 276: 33.
73. 73. KERLIKOWSKE, K., D. GRADY, J. BARCLAY et al. 1996. Likelihood ratios for modern screening mammography: risk of breast cancer based on age and mammographic interpretation. JAMA 276: 39-43.
74. 74. REPORT OF THE ORGANIZING COMMITTEE AND COLLABORATORS, Falun Meeting. 1996. Breast cancer screening with mammography in women aged 40-49 years. Int. J. Cancer 68: 693-699.
75. 75. KERLIKOWSKE, K., D. GRADY, J. BARCLAY et al. 1993. Positive predictive value of screening mammography by age and family history of breast cancer. JAMA 270: 2444.